2. Goals & Objectives
Understand the pathophysiology of DKA
Understand the management approach to
the patient with DKA
Appreciate the complications that can occur
during treatment of DKA
3. Introduction
▶
▶
▶
▶
DKA is a serious acute complications of Diabetes Mellitus.
▶ Significant risk of death and/or morbidity especially with
delayed treatment.
The prognosis of DKA is worse in the extremes of age, with a
mortality rates of 5-10%.
With the new advances of therapy, DKA mortality decreased
to < 2%.
Before discovery and use of Insulin (1922) the mortality was
100%.
4. Epidemiology
DKA is characteristically associated with type 1 DM
It also occurs in type 2 diabetes
Extreme stress
Serious infection
Trauma
Cardiovascular
Other emergencies
5. Pathophysiology
Secondary to insulin deficiency, and the action of counterregulatory hormones, blood glucose increases leading to
hyperglycemia and glucosuria
Glucosuria
osmotic diuresis
water & Na loss
In the absence of insulin activity the body fails to utilize
glucose as fuel and uses fats instead
ketosis
6. Pathophysiology
‣ The excess of ketone bodies will cause metabolic acidosis,
the later is also aggravated by Lactic acidosis caused by
dehydration & poor tissue perfusion.
‣ Vomiting due to an ileus, plus increased insensible water
losses due to tachypnea will worsen the state of
dehydration.
‣ Electrolyte abnormalities are secondary to their loss in urine
& trans-membrane alterations following acidosis & osmotic
diuresis.
7. Pathophysiology
‣
‣
‣
‣
Because of acidosis, K ions enter the circulation leading to
hyperkalemia, this is aggravated by dehydration and renal
failure.
So, depending on the duration of DKA, serum K at diagnosis
may be high, normal or low, but the intracellular K stores are
always depleted.
Phosphate depletion will also take place due to metabolic
acidosis.
Na loss occurs secondary to the hyperosmotic state & the
osmotic diuresis
8. Pathophysiology
The dehydration can lead to decreased kidney perfusion and
acute renal failure.
Accumulation of ketone bodies contributes to the abdominal
pain and vomiting.
The increasing acidosis leads to acidotic breathing and
acetone smell in the breath and eventually causes impaired
consciousness and coma.
10. Risk factors
Age <12 yrs
No first degree diabetic relative
Lower socioeconomic status
High dose glucocorticoids, atypical antipsychotics, diazoxide
and some immunosuppresive drugs
Poor access to medical care
Uninsured
12. Diagnostic Studies in DKA
Chemistry
↑ Glucose > 200
↓ Bicarbonate <15
Anion gap = (Na+) – (Cl- + HCO3-)
Frequently seen:
↑ BUN/creatinine
(dehydration)
↑ potassium
↓ sodium
Blood pH below 7.3
Serum acetones
Positive in DKA
Urinalysis
Ketones (for DKA);
leukocyte esterase, WBC
(for UTI)
CBC
Leukocytosis (possible
infection)
Amylase/Lipase
To evaluate for pancreatitis
BUT, DKA by itself can also
increase them!
EKG
Evaluate for possible MI
13. Laboratory Evaluation
Blood glucose
Electrolytes and osmolality
Bicarbonate, lactate
Calcium and ionized Ca, Mg, P
BUN, creatinine
Blood Gas
CBC and hemoglobin A1c
Blood beta hydroxybutyrate
Urinalysis and urine for ketones
If there is evidence of infection, culture:
blood, urine, throat, wound
EKG for baseline evaluation of intracellular potassium status.
14. Treatment
Monitoring
Consider ICU admission for closer monitoring if:
Severe DKA (pH < 7.1 or < 7.2 in young child)
Altered level of consciousness
Under age of 5 years
Increased risk for cerebral edema
Neurological status
consider neuro checks q 1 hr
How does the patient look TO YOU?
15. Treatment
Goals of treatment of DKA
intravascular volume expansion
correction of deficits in fluids, electrolytes, and acid-base
status
initiation of insulin therapy to correct catabolism,
acidosis
Treatment is divided into 3 phases
treatment of ketoacidosis
transition period
continuing phase and guidance
16. Fluid Therapy
Assume 10-15% dehydration
Begin with a 10-20 ml/kg bolus of NS
Replace calculated deficit evenly over 36 hours generally 1.5 x maintenance for the next several hours
is appropriate
Do not exceed 40ml’s/kg in the initial 4 hours, or 4 L/m²
in 24 hours
Double bag system
NS at 1.5 x M until glucose below 300 mg/dl
D10 NS to be mixed with NS to achieve desired
glucose concentration
17. Insulin Therapy
IV infusion with basal rate 0.1 U/kg/hr
No initial insulin bolus – it will decrease time to correction of
the glucose, but does not alter the time to correction of
acidosis
It may decrease the serum osmolality more rapidly than
desirable
Ideal glucose decline is about 50-100 mg/hr
Continue insulin until urinary (blood) ketones are cleared
18. Potassium & Sodium
Add
potassium when K< 5 and with urination
K >5.5 – no potassium in IVF
K 4.5 – 5.5 – 20 meq/L K+
K <4.5 – 40 meq/L K+
K supplementation
20mEq/L K Acetate + 20mEq/L K Phosphate
early replacement and frequent monitoring
Pseudohyponatremia, add 1.6 mEq of Na to every 100mg/dL
of glucose above normal
Expect that the Na+ level will rise during treatment
If Na+ does not rise, true hyponatremia may be present (risk
of cerebral edema) and should be treated
19. Phosphate
Prevent depletion of RBC 2,3 DPG which will improve tissue
oxygenation as acidosis is resolving
May be useful in patients with anemia, CHF, pneumonia,
hypoxia
Ionized calcium is low, phosphorous should not be given
20. Bicarbonate
Bicarbonate should be used only when there is severe
depression of the circulatory system or cellular metabolism
Not recommended unless pH <7.0, not even then, unless above
true
Bicarbonate administration leads to increased cerebral acidosis
HCO3- + H+ = CO2 + H2O.
Bicarbonate passes the BBB slowly
CO2 diffuses freely
exacerbating cerebral acidosis and cerebral depression
21. Complications
Infection
Precipitates DKA
Fever
Leukocytosis can be secondary to acidosis
Shock
If not improving with fluids r/o MI
Vascular thrombosis
Severe dehydration
Cerebral vessels
Occurs hours to days after DKA
Pulmonary Edema
Result of aggressive fluid resuscitation
Cerebral Edema
First 24 hours
22. Cerebral Edema
Major cause of death in childhood DKA
20% with cerebral edema die
20% with mild to severe neurologic outcomes
At risk:
Younger age
Initial pH < 7.1
Lower pCO2
New onset
Longer duration of symptom
Rapid rehydration (> 50cc/ kg in first 4 hrs)
Hypernatremia/ persistent hyponatremia
Increased BUN
Use of bicarbonate
Lack of an increase in the serum Na during Therapy
23. Cerebral Edema-Pathophysiology
The cause is not fully understood
May be present before treatment has begun, but more
commonly occurs 4 to 12 hours after the initiation of therapy
Numerous factors have been implicated in the
pathophysiology of DKA-related cerebral edema, but none
has been proven
Ischemic
Vasogenic
Osmotic
Cytotoxic processes
24. Cerebral Edema-Pathophysiology
Ischemia/cytotoxic edema
Decrease of N-acetylaspartate (NAA), a marker of
neuronal function or viability in several areas of the brain
Increased lactate production in the basal ganglia
Vasogenic edema
Primary damage to the cerebral vascular endothelium
results in increased BBB permeability or a disturbance in
autoregulation, which permits abnormal diffusion of
intravascular fluids into the cerebral tissues
25. Cerebral Edema-Pathophysiology
Osmotic edema as a consequence of fluid therapy
During the hyperosmolar state of DKA, the brain
produces Idiogenic Osmoles as a compensatory measure
to increase intracellular osmotic pressure and prevent
cerebral dehydration
If the extracellular compartment is at a lower osmolarity
than the intracellular compartment, osmotic pressure
promotes water movement into the intracellular
compartment.
During DKA, the combination of insulin and fluid
repletion lowers the serum glucose and plasma
osmolality, promoting osmotic water movement into the
brain
26. Cerebral Edema
Usually develops several hours after the initiation of therapy
Manifestations:
Headache
Change of mental status
Bradycardia and Hypertension
Sudden onset/return of vomiting
Unequal or fixed, dilated pupils
Treatment:
Mannitol: 1 gram/ kg IV over 30 minutes
Elevate the head of the bed
Decrease IVF rate and insulin infusion rate
ICU management
Do not delay treatment until radiographic evidence
27. Case Scenario #1
A 10 y/o male (~30 kg) presents to the ED with a one-day
history of emesis and lethargy.
Vitals show T 37C, HR 110, RR 25, BP 99/65. Patient is
lethargic, but oriented x 3. Exam reveals the odor of acetone
on the breath, dry lips, but otherwise unremarkable
Labs: pH 7.05, PaCO2 20, PaO2 100, BE -20, Na+ 133, K + 5.2, Cl
96, CO2 8, BS 600. Urine shows 4+ glucose and large ketones
28. Case Scenario #1
How much fluid would you administer as a bolus?
Would you administer bicarbonate?
What is the “true” serum sodium?
How much insulin would you administer?
What IVF would you start? At what rate?
29. Case Scenario #2
A 4 y/o female in the PICU is undergoing treatment for new
onset IDDM and DKA. She is on an insulin infusion at 0.1
u/kg/hr, and fluids are running at 2400 cc/m2/day.
Over the last hour, she has been complaining about
increasing headache. She is now found to be unresponsive
with bilateral fixed and dilated pupils, HR is 50 with BP
150/100.
What is your next step in management?
30. Case Scenario #3
12 year old admitted with:
pH = 7.0
Na= 136, K=3.8, glucose 583mg/ dl
She is oriented and conversant on admission, you follow
the DKA protocol,
2 hours later she becomes difficult to arouse and is
responsive only to deep pain.
What do you do?
Presume cerebral edema
Decrease fluid infusion
Give mannitol: 1 gm/kg
Notas del editor
It is important to stress that IDDM is NOT just a disorder affecting glucose (carbohydrate) metabolism, but that ALL the body’s energy sources are affected.
Diabetic ketoacidosis is characteristically associated with type 1 diabetes. It also occurs in type 2 diabetes under conditions of extreme stress such as serious infection, trauma, cardiovascular or other emergencies, and, less often, as a presenting manifestation of type 2 diabetes, a disorder called ketosis-prone diabetes mellitus.
Neuro status: mental status, level of alertness, arousibility
. have been proposed, as discussed below. It is possible that DKA-related cerebral edema is due to a combination of two or more of these factors. In addition, other metabolic and inflammatory factors, such as hyperglycemia-induced increase in blood-brain barrier permeability, and the generation of new solutes within the brain by hyperglycemia itself and by insulin therapy may contribute to its pathogenesis
*in several areas of the brain, including the basal ganglia and occipital and peri-aqueductal gray matter
10 - 20 cc/kg bolus of NS would be adequate. Though the patient is dehydrated (dry lips), his hemodynamics are good, with acceptable vitals and good perfusion. There would be no reason to administer more than 20 cc/kg fluids.
While this patient is clearly acidemic, he is NOT in impending cardiovascular collapse and therefore there is no justification for the administration of bicarbonate. In fact, administration of bicarbonate has been associated with the development of cerebral edema.
The “true” serum sodium is 143 133 + 0.016[700-100]
Insulin is generally started at 0.1 u/kg/hr. Therefore, in this 30 kg patient, an insulin infusion of 3 u/hr of regular insulin should be initiated.
IVF of 2/3 NS or NS should be started at ~ 2400 cc/m2/day, which is approximately 1.5 x maintenance
This patient is exhibiting cerebral edema, the most feared and lethal complication of DKA.
Management at this point consists of securing the airway by endotracheal intubation and hyperventilating the patient. Mannitol 0.5 - 1 g/kg and or hypertonic saline (~5cc/kg 3% NaCl) should be administered as well.
It would not be appropriate to stop the insulin infusion, or to bolus the patient with glucose. It should be noted that even patients receiving proper management for DKA (like this patient) may nonetheless develop cerebral edema.